{"schema_version":"alpha-profile-public-v1","slug":"frank-e-thomas","canonical_url":"https://registry.alpha.ac/people/frank-e-thomas","as_of":"2026-09-21T22:33:40.042952+00:00","published_at":"2026-09-02T02:37:20.034263+00:00","last_reviewed_at":"2026-05-16T02:43:46.448+00:00","identity":{"display_name":"Frank E. Thomas","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Spero Therapeutics, Inc.","company_slug":"spero-therapeutics-inc","exchange":"NASDAQ","ticker":"SPRO","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","effective_date":"2025-04-28","last_checked_at":"2026-04-28T23:41:00.777+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=frank-e-thomas","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=frank-e-thomas&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Frank E. Thomas has extensive commercial and operational management experience at biopharmaceutical companies including AMAG Pharmaceuticals, Critical Therapeutics, and Orchard Therapeutics. He brings significant expertise in capital markets and financial matters, having served in CFO and COO roles across multiple development-stage and commercial-stage pharmaceutical companies."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Spero Therapeutics, Inc.","organizationId":"spero-therapeutics-inc","title":"Director","period":"2017-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Spero Therapeutics, Inc.","company_slug":"spero-therapeutics-inc","exchange":"NASDAQ","ticker":"SPRO","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","effective_date":"2025-04-28","last_checked_at":"2026-04-28T23:41:00.777+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Frank E. Thomas as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.626456+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"Frank E. Thomas currently serves as Chair at Spero Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-28","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.587943+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Frank E. Thomas serves on Audit.","claim_state":"verified","valid_from":"2025-04-28","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.60889+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Orchard Therapeutics","claim_text":"Frank E. Thomas is linked to Orchard Therapeutics as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.733541+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President and Chief Operating Officer","claim_text":"Frank E. Thomas is also listed as President and Chief Operating Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.715815+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Frank E. Thomas as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.665482+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Frank E. Thomas as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:43:46.64636+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SPRO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T02:43:46.51126+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:frank-e-thomas","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2017-01-01 · current","organization":"Spero Therapeutics, Inc.","organization_id":"spero-therapeutics-inc"},"claim_text":"Director at Spero Therapeutics, Inc. (2017-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/frank-e-thomas#profile","url":"https://registry.alpha.ac/people/frank-e-thomas","dateModified":"2026-05-16T02:43:46.448+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/frank-e-thomas#person","name":"Frank E. Thomas","url":"https://registry.alpha.ac/people/frank-e-thomas","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Spero Therapeutics, Inc.","tickerSymbol":"NASDAQ: SPRO"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2017-01-01","memberOf":{"@type":"Organization","name":"Spero Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/spero-therapeutics-inc","tickerSymbol":"NASDAQ: SPRO"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","name":"SPRO DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/frank-e-thomas"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T02:43:46.448+00:00","observed_at":"2026-09-21T22:33:40.042952+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"frank-e-thomas","canonical_url":"https://registry.alpha.ac/people/frank-e-thomas"},"publication":{"published_at":"2026-09-02T02:37:20.034263+00:00","last_reviewed_at":"2026-05-16T02:43:46.448+00:00","as_of":"2026-09-21T22:33:40.042952+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/frank-e-thomas","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/frank-e-thomas","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/frank-e-thomas.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}